Summary

The global Antibody Humanization market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
United States market for Antibody Humanization is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Antibody Humanization is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Antibody Humanization is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Antibody Humanization players cover Accurus Biosciences, IONTAS, Lonza, Oak BioSciences, Panorama Research, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Antibody Humanization Industry Forecast” looks at past sales and reviews total world Antibody Humanization sales in 2024, providing a comprehensive analysis by region and market sector of projected Antibody Humanization sales for 2025 through 2031. With Antibody Humanization sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Antibody Humanization industry.
This Insight Report provides a comprehensive analysis of the global Antibody Humanization landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Antibody Humanization portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Antibody Humanization market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Antibody Humanization and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Antibody Humanization.
This report presents a comprehensive overview, market shares, and growth opportunities of Antibody Humanization market by product type, application, key players and key regions and countries.
Segmentation by Type:
Monoclonal Antibodies
Bispecific Antibodies
CDR Grafted Antibodies
Segmentation by Application:
HIV
SARS
RSV
Prion
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Accurus Biosciences
IONTAS
Lonza
Oak BioSciences
Panorama Research
PX'Therapeutics
Yurogen Biosystems

ページTOPに戻る

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Antibody Humanization Market Size (2020-2031)
2.1.2 Antibody Humanization Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Antibody Humanization by Country/Region (2020, 2024 & 2031)
2.2 Antibody Humanization Segment by Type
2.2.1 Monoclonal Antibodies
2.2.2 Bispecific Antibodies
2.2.3 CDR Grafted Antibodies
2.3 Antibody Humanization Market Size by Type
2.3.1 Antibody Humanization Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Antibody Humanization Market Size Market Share by Type (2020-2025)
2.4 Antibody Humanization Segment by Application
2.4.1 HIV
2.4.2 SARS
2.4.3 RSV
2.4.4 Prion
2.5 Antibody Humanization Market Size by Application
2.5.1 Antibody Humanization Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Antibody Humanization Market Size Market Share by Application (2020-2025)
3 Antibody Humanization Market Size by Player
3.1 Antibody Humanization Market Size Market Share by Player
3.1.1 Global Antibody Humanization Revenue by Player (2020-2025)
3.1.2 Global Antibody Humanization Revenue Market Share by Player (2020-2025)
3.2 Global Antibody Humanization Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Antibody Humanization by Region
4.1 Antibody Humanization Market Size by Region (2020-2025)
4.2 Global Antibody Humanization Annual Revenue by Country/Region (2020-2025)
4.3 Americas Antibody Humanization Market Size Growth (2020-2025)
4.4 APAC Antibody Humanization Market Size Growth (2020-2025)
4.5 Europe Antibody Humanization Market Size Growth (2020-2025)
4.6 Middle East & Africa Antibody Humanization Market Size Growth (2020-2025)
5 Americas
5.1 Americas Antibody Humanization Market Size by Country (2020-2025)
5.2 Americas Antibody Humanization Market Size by Type (2020-2025)
5.3 Americas Antibody Humanization Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Antibody Humanization Market Size by Region (2020-2025)
6.2 APAC Antibody Humanization Market Size by Type (2020-2025)
6.3 APAC Antibody Humanization Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Antibody Humanization Market Size by Country (2020-2025)
7.2 Europe Antibody Humanization Market Size by Type (2020-2025)
7.3 Europe Antibody Humanization Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Antibody Humanization by Region (2020-2025)
8.2 Middle East & Africa Antibody Humanization Market Size by Type (2020-2025)
8.3 Middle East & Africa Antibody Humanization Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Antibody Humanization Market Forecast
10.1 Global Antibody Humanization Forecast by Region (2026-2031)
10.1.1 Global Antibody Humanization Forecast by Region (2026-2031)
10.1.2 Americas Antibody Humanization Forecast
10.1.3 APAC Antibody Humanization Forecast
10.1.4 Europe Antibody Humanization Forecast
10.1.5 Middle East & Africa Antibody Humanization Forecast
10.2 Americas Antibody Humanization Forecast by Country (2026-2031)
10.2.1 United States Market Antibody Humanization Forecast
10.2.2 Canada Market Antibody Humanization Forecast
10.2.3 Mexico Market Antibody Humanization Forecast
10.2.4 Brazil Market Antibody Humanization Forecast
10.3 APAC Antibody Humanization Forecast by Region (2026-2031)
10.3.1 China Antibody Humanization Market Forecast
10.3.2 Japan Market Antibody Humanization Forecast
10.3.3 Korea Market Antibody Humanization Forecast
10.3.4 Southeast Asia Market Antibody Humanization Forecast
10.3.5 India Market Antibody Humanization Forecast
10.3.6 Australia Market Antibody Humanization Forecast
10.4 Europe Antibody Humanization Forecast by Country (2026-2031)
10.4.1 Germany Market Antibody Humanization Forecast
10.4.2 France Market Antibody Humanization Forecast
10.4.3 UK Market Antibody Humanization Forecast
10.4.4 Italy Market Antibody Humanization Forecast
10.4.5 Russia Market Antibody Humanization Forecast
10.5 Middle East & Africa Antibody Humanization Forecast by Region (2026-2031)
10.5.1 Egypt Market Antibody Humanization Forecast
10.5.2 South Africa Market Antibody Humanization Forecast
10.5.3 Israel Market Antibody Humanization Forecast
10.5.4 Turkey Market Antibody Humanization Forecast
10.6 Global Antibody Humanization Forecast by Type (2026-2031)
10.7 Global Antibody Humanization Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Antibody Humanization Forecast
11 Key Players Analysis
11.1 Accurus Biosciences
11.1.1 Accurus Biosciences Company Information
11.1.2 Accurus Biosciences Antibody Humanization Product Offered
11.1.3 Accurus Biosciences Antibody Humanization Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Accurus Biosciences Main Business Overview
11.1.5 Accurus Biosciences Latest Developments
11.2 IONTAS
11.2.1 IONTAS Company Information
11.2.2 IONTAS Antibody Humanization Product Offered
11.2.3 IONTAS Antibody Humanization Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 IONTAS Main Business Overview
11.2.5 IONTAS Latest Developments
11.3 Lonza
11.3.1 Lonza Company Information
11.3.2 Lonza Antibody Humanization Product Offered
11.3.3 Lonza Antibody Humanization Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Lonza Main Business Overview
11.3.5 Lonza Latest Developments
11.4 Oak BioSciences
11.4.1 Oak BioSciences Company Information
11.4.2 Oak BioSciences Antibody Humanization Product Offered
11.4.3 Oak BioSciences Antibody Humanization Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Oak BioSciences Main Business Overview
11.4.5 Oak BioSciences Latest Developments
11.5 Panorama Research
11.5.1 Panorama Research Company Information
11.5.2 Panorama Research Antibody Humanization Product Offered
11.5.3 Panorama Research Antibody Humanization Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Panorama Research Main Business Overview
11.5.5 Panorama Research Latest Developments
11.6 PX'Therapeutics
11.6.1 PX'Therapeutics Company Information
11.6.2 PX'Therapeutics Antibody Humanization Product Offered
11.6.3 PX'Therapeutics Antibody Humanization Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 PX'Therapeutics Main Business Overview
11.6.5 PX'Therapeutics Latest Developments
11.7 Yurogen Biosystems
11.7.1 Yurogen Biosystems Company Information
11.7.2 Yurogen Biosystems Antibody Humanization Product Offered
11.7.3 Yurogen Biosystems Antibody Humanization Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Yurogen Biosystems Main Business Overview
11.7.5 Yurogen Biosystems Latest Developments
12 Research Findings and Conclusion